LifeMD (LFMD) has provided an update.
Calum MacRae, a distinguished expert with a rich background in cardiovascular medicine and scientific innovation, has recently joined the Board of Directors. His impressive career includes leadership roles at Brigham and Women’s Hospital and Harvard Medical School, and directing a pioneering coronary heart disease research group. MacRae’s appointment is fortified by an incentivizing equity plan that grants him significant stock options, aligning his interests closely with the company’s long-term success.
See more data about LFMD stock on TipRanks’ Stock Analysis page.
